Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Insurance Industry Analysis

UpdatedJun 01, 2026
DataAggregated Company Financials
Companies128
  • 7D-3.9%
  • 3M-6.2%
  • 1Y-13.1%
  • YTD-6.7%

Over the last 7 days, the Insurance industry has dropped 3.9%, driven by a pullback from Chubb of 5.5%. Overall the industry is down 13% in 12 months. As for the next few years, earnings are expected to grow by 2.2% per annum.

Industry Valuation and Performance

Has the U.S. Insurance Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 02 Jun 2026US$1.3tUS$959.6bUS$114.0b10.7x11.1x1.3x
Thu, 30 Apr 2026US$1.3tUS$950.5bUS$109.4b11.7x12.2x1.4x
Sat, 28 Mar 2026US$1.3tUS$946.4bUS$105.4b10.9x12.2x1.4x
Mon, 23 Feb 2026US$1.3tUS$951.3bUS$105.9b12.4x12.7x1.4x
Wed, 21 Jan 2026US$1.3tUS$931.1bUS$99.3b12.6x13.5x1.4x
Fri, 19 Dec 2025US$1.4tUS$931.1bUS$99.3b13.5x14.1x1.5x
Sun, 16 Nov 2025US$1.4tUS$931.1bUS$99.2b13x13.9x1.5x
Tue, 14 Oct 2025US$1.4tUS$919.0bUS$88.6b13.9x15.8x1.5x
Thu, 11 Sep 2025US$1.4tUS$919.1bUS$88.6b14.2x15.8x1.5x
Sat, 09 Aug 2025US$1.4tUS$918.1bUS$88.4b13.9x15.5x1.5x
Mon, 07 Jul 2025US$1.4tUS$903.0bUS$82.1b14.6x17.3x1.6x
Wed, 04 Jun 2025US$1.5tUS$902.7bUS$82.3b14.9x17.9x1.6x
Fri, 02 May 2025US$1.4tUS$894.0bUS$85.0b13.9x16.7x1.6x
Sun, 30 Mar 2025US$1.5tUS$897.3bUS$93.0b14.1x16x1.7x
Tue, 25 Feb 2025US$1.4tUS$895.3bUS$94.3b12.6x14.7x1.6x
Thu, 23 Jan 2025US$1.4tUS$892.9bUS$91.5b12.7x15.1x1.6x
Sat, 21 Dec 2024US$1.3tUS$893.2bUS$91.1b13.1x14.7x1.5x
Mon, 18 Nov 2024US$1.4tUS$893.3bUS$91.0b13.1x15.6x1.6x
Wed, 16 Oct 2024US$1.4tUS$859.2bUS$88.6b14.1x15.8x1.6x
Fri, 13 Sep 2024US$1.4tUS$855.4bUS$87.0b14x15.7x1.6x
Sun, 11 Aug 2024US$1.3tUS$855.4bUS$87.0b13.6x14.8x1.5x
Tue, 09 Jul 2024US$1.2tUS$823.2bUS$79.2b13.4x14.7x1.4x
Thu, 06 Jun 2024US$1.2tUS$823.4bUS$79.2b12.7x14.9x1.4x
Sat, 04 May 2024US$1.1tUS$817.5bUS$78.1b14.1x14.7x1.4x
Mon, 01 Apr 2024US$1.2tUS$792.6bUS$66.9b15.2x18x1.5x
Wed, 28 Feb 2024US$1.1tUS$791.5bUS$66.0b14.7x17.3x1.4x
Fri, 26 Jan 2024US$1.2tUS$794.2bUS$50.0b13.1x23.2x1.5x
Sun, 24 Dec 2023US$1.1tUS$792.9bUS$47.7b12.7x22.8x1.4x
Tue, 21 Nov 2023US$1.1tUS$792.6bUS$47.3b13x22.8x1.4x
Thu, 19 Oct 2023US$1.1tUS$802.3bUS$39.9b15.2x26.7x1.3x
Sat, 16 Sep 2023US$1.0tUS$799.3bUS$38.7b14.8x26.7x1.3x
Mon, 14 Aug 2023US$1.0tUS$799.0bUS$38.5b15.1x26.6x1.3x
Wed, 12 Jul 2023US$994.3bUS$777.8bUS$36.9b15.6x26.9x1.3x
Fri, 09 Jun 2023US$963.8bUS$774.5bUS$35.1b14.5x27.4x1.2x
Price to Earnings Ratio

27.4x


Total Market Cap: US$963.8bTotal Earnings: US$35.1bTotal Revenue: US$774.5bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Insurance Industry Price to Earnings3Y Average 17.4x202420252026
Current Industry PE
  • Investors are pessimistic on the American Insurance industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 11.1x which is lower than its 3-year average PE of 17.4x.
  • The 3-year average PS ratio of 1.5x is higher than the industry's current PS ratio of 1.3x.
Past Earnings Growth
  • The earnings for companies in the Insurance industry have grown 48% per year over the last three years.
  • Revenues for these companies have grown 7.4% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.S. Financials industry?

US Market1.58%
Financials-0.41%
Insurance-3.86%
General Insurance-2.39%
Insurance Brokers-2.40%
Life and Health Insurance-2.44%
Property and Casualty Insurance-4.72%
Reinsurance-6.66%
Industry PE
  • Investors are most optimistic about the Insurance Brokers industry even though it's trading below its 3-year average PE ratio of 36.0x.
    • Analysts are expecting annual earnings growth of 13.3%, which is lower than the prior year's growth of 58.4% per year.
  • Investors are most pessimistic about the Reinsurance industry, which is trading below its 3-year average of 10.5x.
Forecasted Growth
  • Analysts are most optimistic on the Insurance Brokers industry, expecting annual earnings growth of 13% over the next 5 years.
  • However this is lower than its past earnings growth rate of 58% per year.
  • In contrast, the Property and Casualty Insurance industry is expected to see its earnings decline by 4.2% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AJG Arthur J. GallagherUS$206.100.7%
+US$346.9m		-40.9%PE32.9x
LMND LemonadeUS$58.723.9%
+US$169.0m		63.8%PS5.3x
XZO Exzeo GroupUS$14.6012.6%
+US$148.2m		n/aPE16.2x
YB YuanbaoUS$14.9417.6%
+US$103.2m		-1.3%PE2.3x
OSCR Oscar HealthUS$22.971.5%
+US$99.4m		61.1%PS0.5x

Latest News

RYAN
US$33.11
Ryan Specialty Holdings
7D
1.3%
1Y
-54.0%
AJG
US$206.10
Arthur J. Gallagher
7D
0.7%
1Y
-40.9%
Narrative Update • Jun 01

AJG: AI Productivity And Resilient Broker Model Will Drive Future Upside

Analysts have trimmed the Arthur J. Gallagher price target by about $4 to reflect slightly lower fair value assumptions and a modestly higher discount rate, as recent sector research points to slower premium growth, underwriting-driven earnings, and recalibrated expectations for insurance brokers.
CB
US$309.78
Chubb
7D
-5.5%
1Y
3.3%
Narrative Update • Jun 01

CB: Future Dividends And Buybacks Will Support A Stable Fairly Valued Outlook

Analysts have nudged their fair value estimate for Chubb slightly higher from about $344.57 to $345.78, citing updated assumptions around revenue trends, profit margins, and a modestly lower future P/E multiple. What's in the News Piper Sandler and Wells Fargo raised their price targets for Chubb to US$340 and US$333 respectively, while keeping Neutral and Equal Weight ratings.
TRV
US$288.93
Travelers Companies
7D
-5.7%
1Y
4.6%
LMND
US$58.72
Lemonade
7D
3.9%
1Y
63.8%
YB
US$14.94
Yuanbao
7D
17.6%
1Y
-1.3%
OSCR
US$22.97
Oscar Health
7D
1.5%
1Y
61.1%
Narrative Update • May 29

OSCR: Higher Managed Care Optimism Will Clash With Slower Revenue Assumptions

Oscar Health’s updated analyst price target of $30, up from $21, reflects analysts’ view that the recent managed care stock moves after Q1 results are durable, with a relative preference for managed care over facilities given perceived earnings risks for providers tied to inflation and commercial mix. Analyst Commentary Recent research on Oscar Health points to a more balanced stance, with some analysts highlighting upside potential while others flag risks around valuation, execution, and the durability of managed care trends following the latest Q1 updates.
ALL
US$207.21
Allstate
7D
-4.3%
1Y
-2.6%
BWIN
US$20.19
Baldwin Insurance Group
7D
2.7%
1Y
-47.8%
HIG
US$126.57
Hartford Insurance Group
7D
-6.9%
1Y
-2.5%
XZO
US$14.60
Exzeo Group
7D
12.6%
1Y
n/a
AFL
US$112.11
Aflac
7D
-4.9%
1Y
8.0%
Narrative Update • May 26

AFL: Future Returns Will Balance Carrier Focus With Cautious Earnings Assumptions

Analysts have raised their blended price target for Aflac by about $0.20 per share, citing recent stock performance, generally strong life insurance results in Q1, and roll-forward valuation work that now places greater emphasis on carriers rather than brokers. Analyst Commentary Recent Street research on Aflac shows a mix of optimism around execution and caution around valuation and earnings power, with several price target changes in both directions.
AIG
US$73.45
American International Group
7D
-4.7%
1Y
-14.4%
LIFE
US$18.88
Ethos Technologies
7D
6.7%
1Y
n/a
PGR
US$192.67
Progressive
7D
-3.4%
1Y
-33.3%
Narrative Update • May 24

PGR: AI Expense Efficiencies Will Sustain Earnings Power Despite Softer Pricing

Analysts have nudged the fair value estimate for Progressive slightly lower to about $231 from roughly $232, reflecting modest reductions to long term earnings expectations after recent price target cuts tied to April's catastrophe losses and concerns about softer auto pricing power. Analyst Commentary Recent research shows a mix of optimism and caution around Progressive, with price targets being nudged both higher and lower as analysts recalibrate expectations after the April earnings miss and shifting views on auto pricing power.
ACGL
US$88.74
Arch Capital Group
7D
-7.9%
1Y
-7.8%